compounded semaglutide fda news alerts health care providers, compounders and patients of dosing errors associated with injectable products FDA restricts non-approved compounded GLP-1

Liraglutide Promotes Natriuresis But Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 Diabetes

Using alcohol-free mouthwash may also be beneficial

The development of GLP-1 receptor agonists for type 2 diabetes was contextualised within the broader research landscape, including orally bioavailable agonists, allosteric modulators, and unimolecular multi-agonists all of which use the native GLP-1 receptor as their primary target

Lilly reported new data showing its oral obesity drug Foundayo helped women achieve significant weight loss across all stages of menopause

Researchers who are monitoring their own hepatic health should understand that liver fat reduction at the levels seen with retatrutide correlates with improvements in liver enzyme panels, specifically ALT and AST reductions that often normalize within the first 24 weeks of treatment